Sangamo Therapeutics, Inc.SGMONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-38.3%
5Y CAGR-12.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-38.3%/yr
vs +37.6%/yr prior
5Y CAGR
-12.2%/yr
Recent deceleration
Acceleration
-76.0pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $41.92M | -7.3% |
| 2023 | $45.20M | -55.0% |
| 2022 | $100.44M | -43.8% |
| 2021 | $178.87M | +36.2% |
| 2020 | $131.33M | +63.3% |
| 2019 | $80.43M | -42.7% |
| 2018 | $140.42M | +181.8% |
| 2017 | $49.83M | +125.9% |
| 2016 | $22.06M | -68.2% |
| 2015 | $69.48M | - |